Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials

✍ Scribed by Joseph J Eron; Benjamin Young; David A Cooper; Michael Youle; Edwin DeJesus; Jaime Andrade-Villanueva; Cassy Workman; Roberto Zajdenverg; Gerd Fätkenheuer; Daniel S Berger; Princy N Kumar; Anthony J Rodgers; Melissa A Shaughnessy; Monica L Walker; Richard JO Barnard; Michael D Miller; Mark J DiNubile; Bach-Yen Nguyen; Randi Leavitt; Xia Xu; Peter Sklar

• Book ID: 117305904
• Publisher: The Lancet
• Year: 2010
• Tongue: English
• Weight: 149 KB
• Volume: 375
• Category: Article
• ISSN: 0140-6736
• DOI: 10.1016/s0140-6736(09)62041-9